Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :22608565
Publication Date : //

rhAPC reduces the endothelial cell permeability via a decrease of contractile tensions induced by endothelial cells.


All cells generate contractile tension. This strain is crucial for mechanically controlling the cell shape, function and survival. In this study, the CellDrum technology quantifying cell's (the cellular) mechanical tension on a pico-scale was used to investigate the effect of lipopolysaccharide (LPS) on human aortic endothelial cell (HAoEC) tension. The LPS effect during gram-negative sepsis on endothelial cells is cell contraction causing endothelium permeability increase. The aim was to finding out whether recombinant activated protein C (rhAPC) would reverse the endothelial cell response in an in-vitro sepsis model. In this study, the established in-vitro sepsis model was confirmed by interleukin 6 (IL-6) levels at the proteomic and genomic levels by ELISA, real time-PCR and reactive oxygen species (ROS) activation by florescence staining. The thrombin cellular contraction effect on endothelial cells was used as a positive control when the CellDrum technology was applied. Additionally, the Ras homolog gene family, member A (RhoA) mRNA expression level was checked by real time-PCR to support contractile tension results. According to contractile tension results, the mechanical predominance of actin stress fibers was a reason of the increased endothelial contractile tension leading to enhanced endothelium contractility and thus permeability enhancement. The originality of this data supports firstly the basic measurement principles of the CellDrum technology and secondly that rhAPC has a beneficial effect on sepsis influenced cellular tension. The technology presented here is promising for future high-throughput cellular tension analysis that will help identify pathological contractile tension responses of cells and prove further cell in-vitro models.

Authors : Demirci Eylem Kurulgan , Demirci Taylan , Linder Peter , Trzewik Juergen , Gierkowski Jessica Ricarda , Gossmann Matthias , Kayser Peter , Porst Dariusz , Digel Ilya , Artmann Gerhard Michael , Artmann Aysegul Temiz ,

Related products :

Catalog number Product name Quantity
orb81077 Bovine Endothelial Mitogen protein Endothelial Mitogen can be used for Human Mammalian Vascular Endothelial Cells at concentration of 0.1-0.3mg_ml of serum supplemented media 0.01-0.1mg with heparin. 5 mg
20-271-80050 Vascular Endothelial Cell Growth Factor - Mouse Anti Human Vascular Endothelial Cell Growth Factor; VEGF-A; Vascular permeability factor; VPF Monoclonal 0.5 mg
20-271-80050 Vascular Endothelial Cell Growth Factor - Mouse Anti Human Vascular Endothelial Cell Growth Factor; VEGF-A; Vascular permeability factor; VPF Monoclonal 1 mg
20-663-48024 Vascular Endothelial Cell Growth Factor (mAHuVEGF) - Mouse Anti-Human Vascular Endothelial Cell Growth Factor (mAHuVEGF); VEGF-A; Vascular permeability factor; VPF Monoclonal 0.5 mg
20-663-48024 Vascular Endothelial Cell Growth Factor (mAHuVEGF) - Mouse Anti-Human Vascular Endothelial Cell Growth Factor (mAHuVEGF); VEGF-A; Vascular permeability factor; VPF Monoclonal 1 mg
orb82687 Human EMAP 2 protein EMAP 2 is a tumor derived cytokine that exerts a wide range of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculo 1 mg
SCH-MCA1752 MOUSE ANTI PIG ENDOTHELIAL CELLS, Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS, Target Species Pig, Host Mouse, Format S_N, Isotypes IgE, Applications C, Clone MIL11 2 ml
MCA1752 MOUSE ANTI PIG ENDOTHELIAL CELLS, Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS, Target Species Pig, Host Mouse, Format S_N, Isotypes IgE, Applications C, Clone MIL11 2 ml
SCH-4108-2108 RAT ANTI HUMAN ENDOTHELIAL CELLS (FULLY DIFFERENTIATED), Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS , Target Species Human, Host Rat, Format Purified, Isotypes IgG2a, Applic 0.1 mg
4108-2108 RAT ANTI HUMAN ENDOTHELIAL CELLS (FULLY DIFFERENTIATED), Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS , Target Species Human, Host Rat, Format Purified, Isotypes IgG2a, Applic 0.1 mg
orb84810 VEGF165 protein VEGF is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascul 10
4109-0004 MOUSE ANTI HUMAN ENDOTHELIAL CELLS (VEIN ASSOCIATED ANTIGEN), Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS , Target Species Human, Host Mouse, Format S_N, Isotypes IgG2a, Appl 0.5 ml
SCH-4109-0004 MOUSE ANTI HUMAN ENDOTHELIAL CELLS (VEIN ASSOCIATED ANTIGEN), Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS , Target Species Human, Host Mouse, Format S_N, Isotypes IgG2a, Appl 0.5 ml
SCH-4108-2004 MOUSE ANTI HUMAN ENDOTHELIAL CELLS, Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS, Target Species Human, Host Mouse, Format Purified, Isotypes IgG2a, Applications C, P*, Clone 0.5 ml
4108-2004 MOUSE ANTI HUMAN ENDOTHELIAL CELLS, Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS, Target Species Human, Host Mouse, Format Purified, Isotypes IgG2a, Applications C, P*, Clone 0.5 ml
27-910 Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and wat 0.1 mg
26-476 Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and wat 0.05 mg
27-909 Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and wat 0.05 mg
27-907 Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and wat 0.05 mg
27-912 Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and wat 0.1 mg
300-090-L ECGFpro2 (complete for lymphatic ECs) Bovine Host: Cattle Endothelial cell growth factor (ECGF); Endothelial cell growth supplement (ECGS) 6mg
300-090-B ECGFpro1 (complete for blood ECs) Bovine Host: Cattle Endothelial cell growth factor (ECGF); Endothelial cell growth supplement (ECGS) 6mg
300-090H-B ECGFpro1 + Heparin (complete for blood ECs) Bovine Host: Cattle Endothelial cell growth factor (ECGF); Endothelial cell growth supplement (ECGS) 6mg
300-090H-L ECGFpro2 + Heparin (complete for lymphatic ECs) Bovine Host: Cattle Endothelial cell growth factor (ECGF); Endothelial cell growth supplement (ECGS) 6mg
EIAAB12396 ECSCR,ECSM2,Endothelial cell-specific chemotaxis regulator,Endothelial cell-specific molecule 2,Homo sapiens,Human


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur